Kaijun Wang

2 articles listing Kaijun Wang in Nature Communications, Science Advances, indexed by Paperzzz from Crossref and OSF.

1. First-line tislelizumab plus chemotherapy versus placebo plus chemotherapy in unresectable advanced/metastatic esophageal squamous cell carcinoma: minimum 3-year survival follow-up of a randomized phase 3 trial (RATIONALE-306) Nature Communications
2. Electroactive interface–enhanced dielectric elastomer with ultrahigh electroadhesion and multifunctional droplet actuation Science Advances